BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Dr Michel Coleman talks to ecancer at the 8th NCRI Cancer Congress in Liverpool about the disparities of cancer mortality and incidence across the globe. Dr Coleman highlights the EUROCARE study and the effect cancer has on undeveloped and developed countries and the main issues involved in decreasing mortality, such as screening and methods of detection and the ability for quicker drug developments.
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
New classification for identifying HR myeloma based on cytogenetic abnormalities
Best practice in HRRm testing in patients with metastatic prostate cancer
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Colorectal cancer risk factors in Nigeria
The genomics of cancer in Africa
Genomic testing: Awareness and effective communication between healthcare professionals and patients
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for August 4th - 10th, 2023